Christophe Arbet-Engels

Chief Medical Officer, Tempest Therapeutics, Inc.

Companies

Altimmune, Inc.Chief Medical Officer Oct 3, 2025 to now¹
X4 Pharmaceuticals, IncChief Medical Officer Aug 16, 2023 to now²
Tempest Therapeutics, Inc.Chief Medical Officer Feb 11, 2020 to May 27, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

X4 Pharmaceuticals, Inc XFOR864,207 shares⁴$2.2M at $2.56Feb 12, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 12, 2025Granted 850,000 shares of X4 Pharmaceuticals, Inc⁴
Jan 24, 2025Sold 11,624 shares at $0.45 of X4 Pharmaceuticals, Inc⁵
Jan 23, 2025Granted 25,831 shares of X4 Pharmaceuticals, Inc⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAltimmune, Inc., Chief Medical Officer
2
SEC EDGARX4 Pharmaceuticals, Inc, Chief Medical Officer
3
SEC EDGARTempest Therapeutics, Inc., Chief Medical Officer
4
SEC EDGARX4 Pharmaceuticals, Inc shares after the filing of Feb 12, 2025
5
SEC EDGARForm 4 filed Jan 27, 2025